ALEMÁN J.J.; ARTOLA S.; FRANCH J.; MATA
M.; MILLARUELO J.M. y SANGRÓS J.en nombre de la RedGDPS.
Recomendaciones para el tratamiento de la diabetes mellitus tipo 2: control
glucémico. 2014. Disponible en http://wwwredgdps.org/ AMERICAN DIABETES ASSOCIATION. Standards of Medical Care in Diabetes 2015. Diabetes Care. 2015; 38 (Suppl. 1): S1 - S93. BALIUNAS D.O.; TAYLOR B.J.; IRVING H. et al: Alcohol as a Risk Factor for Type 2 Diabetes. A
systematic review and meta-analysis. Diabetes Care 2009; 32: 2123–2132. BARONE B.B.; YEH H.C.; SNYDER C.F. et al: Long-term All-Cause Mortality in Cancer Patients
With Preexisting Diabetes Mellitus. A Systematic Review and Meta-analysis. JAMA.
2008; 300:2754-2764. BELCH J.; MACCUISH A; CAMPBELL I. et al: The prevention of progression of arterial disease
and diabetes (POPADAD) trial: factoria randomised placebo controlled trial of
aspirin and antioxidants in patients with diabetes and asymptomatic peripheral
arterial disease BMJ 2008; 337:a1840 doi:10.1136/bmj.a1840. CANADIAN DIABETES ASSOCIATION CLINICAL PRACTICE
GUIDELINES EXPERT COMMITTEE: Screening for Type 1 and Type 2 Diabetes. Can J Diabetes 2013;
37: S12-S15. CANADIAN DIABETES ASSOCIATION: Clinical Practice Guidelines Expert Committee.
Canadian Diabetes Association 2013 Clinical Practice Guidelines for the
Prevention and Management of Diabetes in Canada. Can J Diabetes 2013;
37 (suppl 1): S1-S212. CAPPUCCIO F.P.; D’ELIA L.; STRAZZULLO P. and MILLER
M.A.: Quantity and
Quality of Sleep and Incidence of Type 2 Diabetes. A systematic review and
meta-analysis. Diabetes Care 2010; 33: 414–420. CARDWELL C.R.; STENE L.C.; JONER G. et al: Caesarean section is associated with an increased
risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of
observational studies. Diabetologia 2008; 51: 726–735. FEDERACIÓN INTERNACIONAL DE DIABETES. Atlas
de la diabetes de la FID. 7ª edición. 2015. Disponible en: http://www.diabetesatlas.org/ GÓMEZ-PERALTA F, et al. Recomendaciones de la Sociedad Española de Diabetes
(SED) para el tratamiento farmacológico de la
hiperglucemia en la diabetes tipo 2: Actualización
2018. Endocrinol Diabetes Nutr. 2018;65:611-24. HANAS R.; JOHN G.ON BEHALF OF THE INTERNATIONAL HBA1C
CONSENSUS COMMITTEE: 2010
Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C
Measurement. Diabetes Care 2010; 33: 1903-1904. HUXLEY R.; LEE C.M.Y.; BARZI F. et al: Coffee, Decaffeinated Coffee, and Tea Consumption in
Relation to Incident Type 2 Diabetes Mellitus. A Systematic Review With
Meta-analysis. Arch Intern Med. 2009; 169: 2053-2063. ISMAIL-BEIGI F.:Glycemic Management of Type 2. Diabetes Mellitus. N
Engl J Med 2012; 366: 1319-27. JOHN W. G. on behalf of the UK
Department of Health Advisory Committee on Diabetes: Expert Position Statement: Use of HbA1cin the
diagnosis of diabetes mellitus in the UK. The implementation of World
Health Organization guidance 2011. Diabet. Med. 2012; 29: 1350–1357. LI L.; SHEN J.; BALA M.M. et al: Incretin treatment and risk of pancreatitis in
patients with type 2 diabetes mellitus: systematic review and meta-analysis of
randomised and non-randomised studies. BMJ 2014;348:g2366 doi: 10.1136/bmj.g2366 LÓPEZ-DE-ANDRÉS A.; MARTÍNEZ-HUEDO M.A.;
CARRASCO-GARRIDO P.; HERNÁNDEZ-BARRERA V.; GIL-DE-MIGUEL A and JIMÉNEZ-GARCÍA
R.: Trends in
Lower-Extremity Amputationsin People With andWithout Diabetes in Spain,
2001–2008. Diabetes Care 2011; 34: 1570–1576. OGAWA H.; NAKAYAMA M.; MORIMOTO T. et al.: Low-Dose Aspirin for Primary Prevention of
Atherosclerotic Events in PatientsWith Type 2 Diabetes. A Randomized Controlled
Trial. JAMA. 2008; 300: 2134-2141. RAY J.G., MOHLLAJEE A.P., VAN DAM R.M and MICHELS
K.B.: Breast size
and risk of type 2 diabetes mellitus. CMAJ 2008; 178: 289-95. SACKS D.B.; ARNOLD
M.; GEORGEL. BAKRIS G.L. et al: Position Statement Executive Summary: Guidelines and Recommendations
for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes
Care 2011; 34: 1419–1423. SORIGUER F.; GODAY A.; BOSCH-COMAS A. et al: Prevalence of
diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2011; 55:88–93. The Emerging Risk Factors Collaboration: Diabetes Mellitus, Fasting Glucose, and Risk of
Cause-Specific Death. N Engl J Med 2011;364:829-41. YEUNG W.G.; RAWLINSON W.D.; CRAIG ME: Enterovirus infection and type 1 diabetes
mellitus:systematic review and meta-analysis of observational molecular
studies. BMJ 2011;342:d35 doi:10.1136/bmj.d35 Páginas web de interés: http://www.idf.org/diabetesatlas/download-book |
